We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

iSpecimen Inc (ISPC) USD0.0001

Sell:$0.37 Buy:$0.38 Change: $0.0234 (5.86%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
Change: $0.0234 (5.86%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
Change: $0.0234 (5.86%)
Market closed |  Prices as at close on 21 June 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

Contact details

450 Bedford St Ste 1010
United States
+1 (781) 3016700

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$4.91 million
Shares in issue:
13.08 million
Health Care Technology
United States
US dollar

Key personnel

  • Tracy Curley
    Chief Executive Officer, Chief Financial Officer, Treasurer
  • Benjamin Bielak
    Chief Information Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.